4//SEC Filing
Western Standard LLC 4
Accession 0000950170-23-040559
CIK 0001274792other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:06 PM ET
Size
18.6 KB
Accession
0000950170-23-040559
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Stock
2023-08-08$12.00/sh+68,431$820,891→ 1,565,111 total(indirect: See footnote) - Purchase
Common Stock
2023-08-07$12.00/sh+49,857$598,468→ 407,371 total(indirect: See footnote) - Purchase
Common Stock
2023-08-07$12.00/sh+84,636$1,015,945→ 1,496,680 total(indirect: See footnote) - Purchase
Common Stock
2023-08-08$12.00/sh+18,626$223,436→ 425,997 total(indirect: See footnote)
Andersen Eric
DirectorOther
Transactions
- Purchase
Common Stock
2023-08-08$12.00/sh+18,626$223,436→ 425,997 total(indirect: See footnote) - Purchase
Common Stock
2023-08-07$12.00/sh+84,636$1,015,945→ 1,496,680 total(indirect: See footnote) - Purchase
Common Stock
2023-08-07$12.00/sh+49,857$598,468→ 407,371 total(indirect: See footnote) - Purchase
Common Stock
2023-08-08$12.00/sh+68,431$820,891→ 1,565,111 total(indirect: See footnote)
Western Standard LLC
Other
Transactions
- Purchase
Common Stock
2023-08-07$12.00/sh+49,857$598,468→ 407,371 total(indirect: See footnote) - Purchase
Common Stock
2023-08-07$12.00/sh+84,636$1,015,945→ 1,496,680 total(indirect: See footnote) - Purchase
Common Stock
2023-08-08$12.00/sh+68,431$820,891→ 1,565,111 total(indirect: See footnote) - Purchase
Common Stock
2023-08-08$12.00/sh+18,626$223,436→ 425,997 total(indirect: See footnote)
Transactions
- Purchase
Common Stock
2023-08-07$12.00/sh+49,857$598,468→ 407,371 total(indirect: See footnote) - Purchase
Common Stock
2023-08-07$12.00/sh+84,636$1,015,945→ 1,496,680 total(indirect: See footnote) - Purchase
Common Stock
2023-08-08$12.00/sh+18,626$223,436→ 425,997 total(indirect: See footnote) - Purchase
Common Stock
2023-08-08$12.00/sh+68,431$820,891→ 1,565,111 total(indirect: See footnote)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.895 to $12.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]The shares are directly held by WSP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F3]The shares are directly held by WSP QP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.90 to $12.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001517666
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:06 PM ET
- Size
- 18.6 KB